FDG-PET imaging showed that patients with established or possible cardiac sarcoidosis with irregular myocardial perfusion and tracer uptake, particularly in the right ventricle, were at higher risk of experiencing adverse events or death. Of 118 patients, 34 had abnormal readings for both metrics with a hazard ratio of 3.9 while those with RV uptake had a hazard ratio of 4.2, indicating a severe condition, according to details in the Journal of the American College of Cardiology. "Our study suggests that inflammation-targeted cardiac PET imaging has a potentially important role in evaluating patients with known or suspected cardiac sarcoidosis," researchers wrote.
Imaging IDs high-risk cardiac sarcoidosis patients
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan